금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Nasdaq Futures Slide Premarket As AI Spending Worries Resurface — Oil Tops $112 On Iran Tensions, Supply Concerns
Lam Research and Tesla led losses as investors reassessed AI spending, while fears of renewed milita...
Tech, Oil Worries Undercut Wall Street Pre-Bell; Asia, Europe Down
Wall Street futures pointed lower pre-bell Thursday on mounting Persian Gulf hostilities and crude p...
Fed preview: On hold in October, hiking resumes later
The Fed began its hiking cycle with a 25bp hike at the September meeting, but we expect rates to sta...
Quanta Services, positioned in markets with superior growth prospects, raised at Oppenheimer
If You Had Invested $1,000 in Micron 1 Year Ago, Here's How Much You'd Have Now. Is the Stock Still a Buy?
The memory chipmaker has staged one of the market's most stunning rallies, crossing $1 trillion in market value this week.
S&P 500 options skew hits a complacency extreme - Tier1 Alpha
Chatbot wars: OpenAI growth slows but still leads rivals in total usage, says Sensor Tower
Musk’s tweet undermines SpaceX’s claims about Anthropic data centre deal
Billionaire says the arrangement, described in IPO filings as a three-year agreement, only lasts for 180 days
USD/SGD: Locked near upper band against US Dollar – UOB
UOB Global Economics & Markets Research highlights that USD/SGD was little changed around 1.2770 in quiet holiday trading, with the Singapore Dollar (SGD) Nominal Effective Exchange Rate (S$NEER) trad ...
Anthropic nears $1 trillion valuation, leapfrogging OpenAI
A $65 billion Series H funding round follows a sharp three-month revenue surge for the Claude creator, pushing Anthropic to a fresh $965 billion valuation.
Buyers likely to support Nikkei futures (NKD) pullback, eyeing 72,870 extension
Nikkei Futures (NKD) continues to demonstrate remarkable strength as it extends into new all‑time highs, reinforcing the bullish sequence that began from the March 23, 2026 low.
Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans
That means millions more Americans may get access to Lilly’s new GLP-1 pill Foundayo or the GLP-1 injection Zepbound.
Burlington outlines FY2026 EPS of $11.45-$11.80 while planning 115 net new stores
Even the Ronald Reagan Institute doesn’t believe the ‘waste, fraud and abuse’ baloney
This may be the single most important issue facing U.S. democracy today.
Lundin Gold launched with Buy rating at UBS on strong and growing free cash flow